L-Cysteine and L-AP4 microinjections in the rat caudal ventrolateral medulla decrease arterial blood pressure

Area of Science:

• Neuroscience
• Cardiovascular Physiology
• Amino Acid Signaling

Background:

• The thiol amino acid L-cysteine centrally increases arterial blood pressure (ABP).
• L-cysteine exhibits affinity for L-2-amino-4-phosphonobutyric acid (L-AP4) binding sites, suggesting potential mediation via L-AP4 sensitive receptors.
• The caudal ventrolateral medulla (CVLM) is a critical autonomic area regulating ABP through inhibitory neurons acting on pre-sympathetic vasomotor neurons.

Purpose of the Study:

• To investigate the cardiovascular responses to L-cysteine and L-AP4 microinjected into the CVLM.
• To elucidate the receptor mechanisms underlying L-cysteine and L-AP4 actions in the CVLM.
• To determine if L-cysteine's cardiovascular effects are mediated by L-AP4 sensitive receptors.

Main Methods:

• Microinjection of L-cysteine and L-AP4 into the CVLM of urethane-anesthetized rats.
• Assessment of cardiovascular responses, including arterial blood pressure (ABP) and heart rate.
• Pharmacological blockade of N-methyl-D-aspartate (NMDA) and non-NMDA receptors using MK801 and CNQX, respectively.

Main Results:

• Microinjection of L-cysteine and L-AP4 into the CVLM induced depressor and bradycardic responses.
• L-cysteine-induced responses were abolished only by combined NMDA and non-NMDA receptor blockade.
• L-AP4-induced responses were abolished by blockade of either NMDA or non-NMDA receptors alone, indicating distinct mechanisms.

Conclusions:

• The CVLM is a central active site for L-cysteine's cardiovascular effects.
• L-cysteine's central action in the CVLM appears independent of L-AP4 sensitive receptors.
• Endogenous L-cysteine may play a role in cardiovascular regulation within the CVLM, warranting further investigation.